Pain Management
Neuropathic pain reduction correlates with improved quality of life
Published in Medical Letter on the CDC and FDA, July 9th, 2006
According to recent research from Canada, "Mood and duality of life (QOL) outcomes vary widely in neuropathic pain trials. This may be a result of variable analgesia and other treatment effects. We evaluated the relationship between pain reduction and mood/QOL in neuropathic pain. Pain, side effects, QOL, and mood from a trial of morphine, gabapentin, and a morphine-gabapentin combination were examined. Baseline QOL was impaired according to Short Form Health Survey (SF-36) scores. Baseline mood, according to Profile of Mood States scores, was comparable to that of a nondepressed population."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Food-Borne Illness
Salmonella Heidelberg outbreaks in U.S. traced to poultry and eggs - Food-Borne Illness
Aging of cheese made from unpasteurized milk does not eliminate Escherichia coli O157:H7 - HIV/AIDS Diagnosis
HIV RNA testing improves diagnosis of HIV infection in high-risk patients - Hepatitis E Virus
Locally acquired hepatitis E virus infection in Texas reported - Sexual & Reproductive Health
High-risk behaviors linked to Viagra use among men who have sex with men - Acute Myelogenous Leukemia
CuraGen and TopoTarget announce NCI-sponsored Phase II clinical trial with PXD101 for AML - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
